Structural Heart Imaging Market Size, Share & Trends Analysis Report By Modality (Echocardiogram, Angiogram), By Procedure (TAVR, SAVR, TMVR), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Structural Heart Imaging Market Trends

The global structural heart imaging market size was valued at USD 8.84 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The major factors driving the growth of the structural heart imaging market are the increasing prevalence of various congenital, increase in cardiac diseases and lifestyle-related illnesses like diabetes, high blood pressure because of high alcohol consumption, and poor diet.

The rising awareness about health and fitness among consumers is positively impacting the global market. The increase in structural heart imaging (SHI) for resolving various heart disorders such as non-valvular and valvular heart disorders as it has high accuracy and resolution cameras and sensors is also impacting positively the growth of the market, the increase in usage of transcatheter aortic valve replacement procedure in operating the heart disorders has resulted in faster recovery of the patients which is also the growth factor for the market.

Research and development in the field resulting in the introduction of advanced structural heart imaging systems has created a positive image in the market. The improving healthcare infrastructure by various countries' governments will also impact the market positively. The key market players are heavily involved in research and development activities to launch new devices with improved capabilities. Some capabilities include 3D and 4D imaging, virtual procedures, and real-time visualization. The barriers that affect the market growth include the high cost of imaging technologies, safety concerns, and uncertainty in availability.

Modality Insights

The angiogram accounted as the most dominant segment with a share of 31.7% in 2023. During angiography, the devices detect heart failures and other cardiovascular diseases. Enhanced devices, sophisticated techniques, increased research activities, and huge funding from government and private entities are the major growth factors for the market.

The echocardiogram segment accounted for a significant market share in 2023. The procedure involves sound techniques and variations to treat patients with heart and cardiovascular diseases. The major growth factors for the popularity of echocardiograms are mainly because of the rise in heart-related disorders such as heart arrhythmias, heart valve disease, and heart failure. The changing lifestyle and diet patterns such as lack of physical activities, diet with high saturated fats, and cholesterol mainly contribute to the heart conditions in the population.

Computed Tomography (CT) is expected to be the fastest-growing segment with a CAGR of 8.1% during the forecast period. The major factors attributed to the market growth include a rise in the geriatric population, growing demand to identify treatment efficiency, and rising demand for computed tomography systems.

Procedure Insights

The transcatheter aortic valve replacement (TAVR) is the most dominant segment in the structural heart imaging market with a share of 34.8% in 2023. TAVR is primarily used in the treatment of high-risk heart disorder patients. TAVR is a less invasive alternative compared to the traditional treatment. Due to the minimally invasive nature of TAVR, quick recovery of patients and a decline in operative complications have enhanced the use of TAVR. This has positively impacted the market growth.

The surgical aortic valve replacement (SAVR) segment is expected to register a significant CAGR of 6.0% over the forecast period. SAVR is mainly used in the treatment of severe aortic valve diseases. The major factors that positively impact segment growth include a rise in the geriatric population with aortic valve problems, improved valve designs, and the creation of new bio-compatible materials. The increase in prosthetic heart valves which are more effective and long-lasting enhances patient recovery which is also helping in the growth of the segment.

End-use Insights

Hospitals accounted for a significant market share of 54.7% in 2023. The dominance can be attributed to the availability of skilled professionals, advanced devices, and improved healthcare infrastructure of hospitals and clinics which is the factor influencing positively the dominance and market growth.

The ambulatory surgical centers are fast-growing with a CAGR of 6.8% during the forecast period. An increase in the infrastructure, availability of equipment, and cost-effective procedures have been major factor for patients to opt for ambulatory surgical clinics. This has a positive impact on the segment growth.

The diagnostic imaging centers held a significant market share in 2023. The rise in the number of imaging centers and the cost-effective alternatives are the major growth parameters. The diagnostic centers are easily accessible to patients. Besides, a diagnostic imaging center is a crucial component in disease treatment. It helps identify the severity of heart disease in a particular case and enables the clinician to pursue a relevant course of action. Therefore, the rise in the importance of diagnostic imaging centers from a clinical aspect boosts segment development.

Application Insights

The valvular heart disease segment was the most dominant segment with a share of 32.0% in 2023. Factors such as old age, infections such as rheumatic fever or blood infections, heart attacks, and high cholesterol are the primary reasons for the segment growth. Poor diet and smoking habits also contribute to the condition.

Congenital heart disease is anticipated to register a CAGR of 6.8% during the forecast period. The major reason for the segment growth can be attributed to the increase in birth rates as congenital heart diseases are attributed to heart structure or shape by birth.

Regional Insights

North America held a dominant position in the global market accounting for 35.9% in 2023, due to an increase in the number of patients with cardiovascular diseases, funding for research, and high spending on healthcare infrastructure. The increase in alcohol and smoking has led to a rise in cardiovascular diseases. This has enhanced the demand for advanced heart treatment equipment. In 2022, according to a WHO guideline that addresses chest imaging in follow-up patients’ post-recovery, the guideline indications remain unaltered in version one and put more value on chest imaging to monitor the development of COVID-19 sequela.

U.S Structural Heart Imaging Market Trends

The U.S. is the most dominant region in North America with a total market share of 79.9% in 2023. This dominance can be attributed to the increase in heart diseases among the people. Poor lifestyle and an increase in consumption of alcohol and sugar have been the leading causes of heart disease in the urban population. The presence of major healthcare organizations launching new products to improve the conditions of patients is also the driving factor for market growth.

Asia Pacific Structural Heart Imaging Market Trends

Asia Pacific structural heart imaging market is fast-growing with a CAGR of 6.5% over the forecast period. The growth factors can be attributed to the rise in funding for research for cardiovascular conditions, the rise in heart diseases, and an increase in the geriatric population. The high prevalence of the population suffering from high blood pressure, and lack of physical activities are the major drivers for the market growth.

India structural heart imaging market accounted for a notable market share in 2023. It is one of the biggest markets in the Asia Pacific due to a huge patient pool with heart conditions and the need for medical imaging services. The pursuit of an unhealthy lifestyle, lack of health awareness, and work-related stress are major causes of developing heart diseases in the population.

Europe Structural Heart Imaging Market Trends

Europe was the second dominant region in the global market in 2023. The increase in the geriatric population and a rise in the consumption of high-sugar and junk foods have increased the chance of heart disease in the young population. Developed medical infrastructure and access to medical imaging services have added to the population's awareness.

The UK structural heart imaging market possesses a high number of cardiovascular, and diabetic patients. Incessant smoking and alcohol consumption are the leading causes of heart-related diseases. The Royal Brompton and Harefield Hospitals, UK have listed several factors such as fistula, atrial septal defect, pseudoaneurysm, and ventricular septal defect, which form the defects for structural heart disease.

Key Structural Heart Imaging Company Insights

The key companies in the structural heart imaging market include GE Healthcare and Siemens Healthineers AG. Organizations focus on growing customer base to gain a competitive edge in the industry. Therefore, key players are following several strategic initiatives, such as mergers and acquisitions, and partnerships with major companies. 

• GE Healthcare is a key player in the medical technology industry which focuses on providing innovative medical imaging equipment like CT scanners, and MRIs. The company’s offerings include diagnostic tools and patient monitoring systems to improve patient health.

• Koninklijke Philips N.V. is among the prominent players in medical technology to provide medical equipment such as medical imaging equipment mainly used in structural heart imaging which helps improve patient health.

Recent Developments

• In October 2023, GE Healthcare launched its enhanced venue family point-of-care ultrasound system with features like AI-driven caption guidance. That allows the surgeon to perform cardiac examination with real-time guidance.

• In August 2023, Canon Medical announced the launch of their new angiography system Alphe Cnix/Evolve Edition for commercial sale in Asian, African, and European countries.

Structural Heart Imaging Market Report Scope

Global Structural Heart Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global structural heart imaging market report based on modality, procedure, application, end use, and region: 

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Echocardiogram

  • Angiogram

  • CT

  • MRI

  • Nuclear Imaging

  • Others

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Transcatheter Aortic Valve Replacement (TAVR)

  • Surgical Aortic Valve Replacement (SAVR)

  • Transcatheter Mitral Valve Repair (TMVR)

  • Left Atrial Appendage Closure (LAAC)

  • Annuloplasty

  • Valvuloplasty

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Diagnostic Imaging Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Mexico

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Spain

    • Denmark

    • Italy

    • Norway

    • Sweden

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • Saudi Arabia

    • UAE

    • Kuwait

    • South Africa